---
figid: PMC2706980__nihms95289f5
figlink: /pmc/articles/PMC2706980/figure/F5/
number: Fig. 5
caption: Schematic representation of molecular changes from acute psychostimulant
  exposure to persistent molecular changes in the nucleus accumbens (NAc) and dorsal
  striatum. A, Acute exposure to psychostimulant increases synaptic dopamine and glutamate
  in the nucleus accumbens and dorsal striatum. Dopamine binds postsynaptic D1 receptors
  and activates the cyclic AMP (cAMP) second-messenger pathway. cAMP activates protein
  kinase A (PKA) that phosphorylates several target molecules including NMDA and AMPA
  receptors and L-type Ca2+ channels (LTCCs), resulting in an increase in intracellular
  Ca2+ (High [Ca2+]i) and activation of Ca2+/CaM (calmodulin) kinases. PKA also phosphorylates
  downstream signaling molecules including dopamine and adenosine 3′, 5′- monophosphate
  regulated phosphoprotein 32 (DARPP-32) and CREB. Phosphorylation of DARPP-32 at
  Thr 34 (P-DARPP-32) converts it to a potent inhibitor of protein phosphatase 1 (PP1),
  a phosphatase that dephosphorylates CREB. Inhibition of PP1 and activation of PKA
  result in an increase in CREB phosphorylation that activates downstream acute gene
  expression. B, Following chronic psychostimulant exposure, under conditions of low
  intracellular Ca2+ (Low [Ca2+]i), L-type Ca2+ channels would activate Ca2+/CaMdependent
  calcineurin (PP2B), resulting in dephosphorylation of its targets that include AMPA
  receptors and DARPP-32. DARPP-32 in its dephosphorylated state no longer would inhibit
  PP1, resulting in dephosphorylation of CREB and alteration of CREB-mediated gene
  expression. DA = dopamine; GLU = glutamate; CRE = cyclic AMP and calcium response
  element; AP1 = Activator Protein 1.
pmcid: PMC2706980
papertitle: Psychostimulants, L-type Calcium Channels, Kinases, and Phosphatases.
reftext: Anjali M. Rajadhyaksha, et al. Neuroscientist. ;11(5):494-502.
pmc_ranked_result_index: '124583'
pathway_score: 0.8806696
filename: nihms95289f5.jpg
figtitle: Molecular changes from acute psychostimulant exposure to persistent molecular
  changes in the nucleus accumbens (NAc) and dorsal striatum
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2706980__nihms95289f5.html
  '@type': Dataset
  description: Schematic representation of molecular changes from acute psychostimulant
    exposure to persistent molecular changes in the nucleus accumbens (NAc) and dorsal
    striatum. A, Acute exposure to psychostimulant increases synaptic dopamine and
    glutamate in the nucleus accumbens and dorsal striatum. Dopamine binds postsynaptic
    D1 receptors and activates the cyclic AMP (cAMP) second-messenger pathway. cAMP
    activates protein kinase A (PKA) that phosphorylates several target molecules
    including NMDA and AMPA receptors and L-type Ca2+ channels (LTCCs), resulting
    in an increase in intracellular Ca2+ (High [Ca2+]i) and activation of Ca2+/CaM
    (calmodulin) kinases. PKA also phosphorylates downstream signaling molecules including
    dopamine and adenosine 3′, 5′- monophosphate regulated phosphoprotein 32 (DARPP-32)
    and CREB. Phosphorylation of DARPP-32 at Thr 34 (P-DARPP-32) converts it to a
    potent inhibitor of protein phosphatase 1 (PP1), a phosphatase that dephosphorylates
    CREB. Inhibition of PP1 and activation of PKA result in an increase in CREB phosphorylation
    that activates downstream acute gene expression. B, Following chronic psychostimulant
    exposure, under conditions of low intracellular Ca2+ (Low [Ca2+]i), L-type Ca2+
    channels would activate Ca2+/CaMdependent calcineurin (PP2B), resulting in dephosphorylation
    of its targets that include AMPA receptors and DARPP-32. DARPP-32 in its dephosphorylated
    state no longer would inhibit PP1, resulting in dephosphorylation of CREB and
    alteration of CREB-mediated gene expression. DA = dopamine; GLU = glutamate; CRE
    = cyclic AMP and calcium response element; AP1 = Activator Protein 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAR2B
  - PRKAR2A
  - PRKAR1B
  - JUN
  - PRKAR1A
  - CREM
  - CREB3L4
  - CREB3
  - FOS
  - PRKACG
  - PRKACB
  - CREB1
  - PPP1R1B
  - FOSL1
  - NLRP1
  - PRKACA
  - ATF2
  - CREB5
  - CREB3L2
  - FOSL2
  - CREB3L1
  - JUNB
  - FOSB
  - CREB3L3
  - ATF1
  - JUND
  - AMPA
genes:
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: DARPP-32
  symbol: DARPP-32
  source: hgnc_alias_symbol
  hgnc_symbol: PPP1R1B
  entrez: '84152'
- word: Fos
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: NAc/STRIATAL
  symbol: NAC
  source: hgnc_alias_symbol
  hgnc_symbol: NLRP1
  entrez: '22861'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
chemicals:
- word: AMPA
  source: MESH
  identifier: D018350
diseases: []
---
